BLIMP-1 mediated regulation of CD8+ TIL
BLIMP-1 介导的 CD8 TIL 调节
基本信息
- 批准号:8777888
- 负责人:
- 金额:$ 32.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-01-01 至 2015-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAntibodiesAntigensAutologousBloodCD8B1 geneCancer ControlCancer VaccinesCell physiologyCellsChronicCytotoxic T-LymphocytesDataDevelopmentDiagnostic Neoplasm StagingExhibitsFunctional disorderGoalsHumanIL2 geneImmunotherapyIndiumInfiltrationInterferonsInterventionLinkLymphocyteLymphocyte FunctionMediatingMemoryModelingMusNeoplasm TransplantationPRDM1 genePatientsPlayProductionRegulationRoleSensitivity and SpecificitySurfaceT-LymphocyteTranscription Repressor/CorepressorTumor AntigensTumor stageTumor-Infiltrating LymphocytesVirus Diseasesbasecancer immunotherapyclinically relevantcytokinedesignfunctional restorationfunctional statusgenome-widemalignant breast neoplasmmelanomaoutcome forecastpathogenpreventpromoterpublic health relevancereceptorreceptor expressionresponsetranscription factortumor
项目摘要
DESCRIPTION (provided by applicant): The exquisite sensitivity and specificity of T cells for their targets offers considerable promise for the use of immunotherapy in cancer control. However, in many instances, T cells found within tumors are dysfunctional. A major cause for this dysfunctional state is the expression of inhibitory molecules. We have found that the expression of inhibitory molecules by both murine and human tumor infiltrating CD8+ cytotoxic T cells correlates strongly with the expression of the transcription factor BLIMP-1. In this application we show that tumor infiltrating CD8+ T cells over-express BLIMP-1 compared to CD8+ T cells responding to acute viral infection. We show that limiting BLIMP-1 expression in tumor infiltrating lymphocytes results in reduced inhibitory molecule expression and increased functional activity. Further, we show that BLIMP-1 expression controls CD8+ T cell function beyond the expression of inhibitory molecules. From these data, we propose to pursue studies that will define how BLIMP-1 expression is regulated in tumor infiltrating lymphocytes, and will determine how BLIMP-1 expression regulates tumor infiltrating lymphocyte function. The studies presented here will illuminate the mechanisms behind tumor infiltrating lymphocyte dysfunction, and will provide opportunities to develop interventions that either prevent dysfunction, or restore
activity.
描述(由申请人提供):T细胞对其靶标的灵敏度和特异性为在癌症控制中使用免疫疗法提供了相当大的希望。然而,在许多情况下,肿瘤内发现的T细胞功能失调。这种功能障碍状态的主要原因是抑制性分子的表达。我们已经发现,小鼠和人肿瘤浸润性CD 8+细胞毒性T细胞的抑制性分子的表达与转录因子BLIMP-1的表达密切相关。在本申请中,我们表明,与响应急性病毒感染的CD 8 + T细胞相比,肿瘤浸润性CD 8 + T细胞过表达BLIMP-1。我们表明,限制肿瘤浸润淋巴细胞中的BLIMP-1表达导致抑制性分子表达减少和功能活性增加。此外,我们表明,BLIMP-1的表达控制CD 8 + T细胞的功能超出了抑制分子的表达。从这些数据中,我们建议进行研究,以确定如何在肿瘤浸润淋巴细胞中调节BLIMP-1表达,并确定BLIMP-1表达如何调节肿瘤浸润淋巴细胞功能。这里介绍的研究将阐明肿瘤浸润淋巴细胞功能障碍背后的机制,并将提供机会开发干预措施,无论是预防功能障碍,或恢复
活动
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIMOTHY N BULLOCK其他文献
TIMOTHY N BULLOCK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIMOTHY N BULLOCK', 18)}}的其他基金
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
与黑色素瘤免疫疗法协同作用的聚焦超声治疗方案
- 批准号:
10186745 - 财政年份:2020
- 资助金额:
$ 32.62万 - 项目类别:
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
与黑色素瘤免疫疗法协同作用的聚焦超声治疗方案
- 批准号:
10032967 - 财政年份:2020
- 资助金额:
$ 32.62万 - 项目类别:
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
与黑色素瘤免疫疗法协同作用的聚焦超声治疗方案
- 批准号:
10377443 - 财政年份:2020
- 资助金额:
$ 32.62万 - 项目类别:
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
与黑色素瘤免疫疗法协同作用的聚焦超声治疗方案
- 批准号:
10615036 - 财政年份:2020
- 资助金额:
$ 32.62万 - 项目类别:
Leveraging MR-Guided Focused Ultrasound to Potentiate Immunotherapy for GBM
利用 MR 引导聚焦超声增强 GBM 免疫治疗
- 批准号:
10020956 - 财政年份:2019
- 资助金额:
$ 32.62万 - 项目类别:
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
通过 MR 引导聚焦超声将免疫治疗纳米颗粒递送至黑色素瘤
- 批准号:
8945980 - 财政年份:2015
- 资助金额:
$ 32.62万 - 项目类别:
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
通过 MR 引导聚焦超声将免疫治疗纳米颗粒递送至黑色素瘤
- 批准号:
9267820 - 财政年份:2015
- 资助金额:
$ 32.62万 - 项目类别:
BLIMP-1 mediated regulation of CD8+ TIL
BLIMP-1 介导的 CD8 TIL 调节
- 批准号:
8844054 - 财政年份:2014
- 资助金额:
$ 32.62万 - 项目类别:
BLIMP-1 mediated regulation of CD8+ TIL
BLIMP-1 介导的 CD8 TIL 调节
- 批准号:
8595301 - 财政年份:2013
- 资助金额:
$ 32.62万 - 项目类别:
BLIMP-1 mediated regulation of CD8+ TIL
BLIMP-1 介导的 CD8 TIL 调节
- 批准号:
8439016 - 财政年份:2013
- 资助金额:
$ 32.62万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 32.62万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 32.62万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 32.62万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 32.62万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 32.62万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 32.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 32.62万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 32.62万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 32.62万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 32.62万 - 项目类别:
Standard Grant














{{item.name}}会员




